Anemia is one of the most common complications affecting individuals with chronic kidney disease (CKD). It is driven primarily by relative erythropoietin (EPO) deficiency, chronic inflammation, and altered iron metabolism. Emerging therapies, known as hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs), o...
Joel Shah, W. Wells-Gatnik, Kunal Sharma et al.· Clinical Nephrology· 0 citations
Current HF management is increasingly phenotype- and trajectory-guided, but its clinical adoption is limited by optimal implementation and access barriers, so future research should focus on outcomes-based validation with a clear patient-selection framework to enable durable real-world implementation to improve outcome...
Lakshmi Kattamuri, Kunal Sharma, Debabrata Mukherjee· International Journal of Ang...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.